Optimizing patient access with evidence of product value, effectiveness, and safety from early development through loss of exclusivity.

Learn More
Statistics Background

Our Work In Action

130+ Payer Submissions

across 20+ countries in the past 5 years, including reversal of multiple NICE decisions

12 of the 15 Top-Selling Drugs

in 2016 supported in the past 5 years

150+ Drugs/Therapies

supported in the past year

30+ Global Extended Access Programs

in the last 3 years alone with thousands of patients transitioning smoothly from investigational to commercial

150+ Peer-Reviewed Publications

and 250+ research posters and presentations per year

Learn More

Latest Publications

What We Do

In Our Own Words

Our work simulating Alzheimer’s disease progression allows us to offer clients insight into their trial designs, simulate outcomes of alternative designs, and enable clients to anticipate results and make decisions accordingly.

Prostate Cancer
CUP Case Study
Case Study

Robust Modeling Helped Convince NICE to Reverse Their Decision

Learn how Evidera’s experts helped to improve access to a mCRPC treatment in a country with traditionally conservative reimbursement for these therapies.

Read More
Case Study

Compassionate Use Program: Rapid Drug Delivery to Patients in Need

Learn how Evidera, as part of PPD, created a global program across 38 countries to provide treatment within 24-48 hours to 3,100 patients.

Read More
Careers

Meaningful Work at Every Level

We assess candidates across a variety of scientific and operational functions. From leaders in their fields, to those who are new to the industry. We employ people who have a proactive mind-set when it comes to the work they do and helping the people they work with.

Learn More
synergy in the office